Loading...
XSHG
600771
Market cap992mUSD
Jul 10, Last price  
14.23CNY
1D
3.42%
1Q
-18.92%
Jan 2017
-40.42%
Name

GuangYuYuan Chinese Herbal Medicn Co Ltd

Chart & Performance

D1W1MN
XSHG:600771 chart
P/E
110.49
P/S
5.09
EPS
0.13
Div Yield, %
Shrs. gr., 5y
-0.19%
Rev. gr., 5y
4.30%
Revenues
1.37b
+12.11%
626,907,000531,192,256307,725,961254,522,269228,463,737226,537,698260,653,805268,111,310354,154,539428,436,063936,993,2281,168,684,8141,618,764,0091,217,097,4701,109,430,046854,223,1471,130,720,5581,284,015,7511,221,426,2761,369,303,098
Net income
63m
-15.32%
20,909,708-768,342,951286,950,980-147,641,708193,629,030299,716,482355,571,487-19,563,99536,646,3892,030,312122,810,072236,804,806374,108,056130,068,25232,003,006-316,244,434-250,021,53690,078,57074,453,02363,043,502
CFO
198m
+76.07%
178,973,162108,060,096035,171,445000000000-140,819,718-75,524,82781,368,872253,426,205215,499,935112,391,418197,891,808
Dividend
Jul 30, 20030.0648 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

GuangYuYuan Chinese Herbal Medicine Co., Ltd. specializes in the production and sale of traditional Chinese pharmaceutical goods. Their comprehensive range includes both classic and high-quality Chinese medicines, in addition to health-boosting wines. These remedies are available in diverse formats, such as pills, powders, tablets, hard capsules, granules, oral liquids, decoctions, and various wine preparations. The enterprise, which previously operated as Topsun Science And Technology Co Ltd., adopted its current name, GuangYuYuan Chinese Herbal Medicine Co., Ltd., in July 2013. Its primary operations are located in Xi'an, China.
IPO date
Nov 05, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT